Neogen Corporation

NEOG ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Revenue $870.4M $894.7M $924.2M $822.4M $527.2M $468.5M $418.2M $414.2M
Cost of Revenue $461.9M $473.3M $460.3M $416.5M $284.1M $253.4M $221.9M $222.3M
Gross Profit $408.5M $421.4M $463.9M $406.0M $243.0M $215.1M $196.3M $191.9M
Gross Margin 46.9% 47.1% 50.2% 49.4% 46.1% 45.9% 46.9% 46.3%
Operating Expenses
Research & Development $18.4M $21.1M $22.5M $26.0M $17.0M $16.2M $14.8M $12.8M
SG&A Expense $245.1M $218.2M $199.9M $201.2M $82.7M $51.2M $44.3M $40.8M
Operating Income $-21.6M $-1.06B $58.6M $37.5M $58.6M $74.2M $67.5M $68.1M
Operating Margin -2.5% -118.6% 6.3% 4.6% 11.1% 15.8% 16.1% 16.4%
Interest Expense $24.1M $38.1M $42.2M $27.3M
Pretax Income $-9.0M $-1.13B $-14.3M $-22.0M $60.2M $75.3M $72.3M $73.0M
Income Tax Expense $-1.1M $-41.1M $-4.9M $828.0K $11.9M $14.4M $12.8M $12.8M
Net Income $-7.9M $-1.09B $-9.4M $-22.9M $48.3M $60.9M $59.5M $60.2M
Net Margin -0.9% -122.1% -1.0% -2.8% 9.2% 13.0% 14.2% 14.5%
EPS (Basic) $-0.04 $-5.03 $-0.04 $-0.12 $0.45 $0.57 $0.57 $0.58
EPS (Diluted) $-0.04 $-5.03 $-0.04 $-0.12 $0.45 $0.57 $0.56 $0.57
Shares Outstanding (Basic) 217.5M 216.9M 216.5M 188.9M 107.7M 106.5M 105.1M 103.8M
Shares Outstanding (Diluted) 217.5M 216.9M 216.5M 188.9M 108.0M 107.1M 105.7M 104.9M
Dividends Per Share
← Newer Page 1 of 3 Older →